AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (August 19, 2005). doi:10.1152/ajplung.00221.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/L105    most recent
00221.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hartney, J. M
Right arrow Articles by Koller, B. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartney, J. M
Right arrow Articles by Koller, B. H
Submitted on May 19, 2005
Accepted on August 5, 2005

Prostaglandin E2 protects lower airways against broncoconstriction

John M Hartney1, Kenneth G Coggins2, Stephen L Tilley2, Leigh A Jania3, Alysia Kern Lovgren1, Laurent P Audoly4, and Beverly H Koller5*

1 Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
2 Deoartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
3 Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
4 Department of Pharmacology, Merck Frosst Canada, Kirkland, Quebec, Canada
5 Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Deoartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

* To whom correspondence should be addressed. E-mail: treawouns{at}aol.com.

Prostaglandin E2 (PGE2), similar to {beta}-adrenergic receptor agonists, can protect airways from bronchoconstriction and resulting increase in airway resistance induced by a number of agents including cholinergic receptor agonists and antigen. Here we examine the impact of sustained alterations in PGE2 pathways on changes in airway resistance. Genetic methods were utilized to alter PGE2 metabolism and signal transduction in the murine lung. PGE2 levels were elevated by generating mice lacking 15-hydroxyprostaglandin (HPGD), the major catabolic enzyme of PGE2 and by generating a transgenic line, in which mouse PGE2 synthase (Ptges) expression is driven by a lung specific promoter, hSP-C. Conversely, to determine the impact of loss of PGE2 on airway reactivity, we examine mice lacking this synthase (Ptges-/-) and receptors which mediate the actions of PGE2, particularly the PGE2 EP2 receptor (Ptger2). Diminished capacity to produce and respond to PGE2 does not alter the response of mice to cholinergic stimuli. In contrast, the responsiveness to cholinergic stimulation is dramatically altered in animals with elevated PGE2 levels. The Hpgd-/- and hSP-C-Ptges transgenic lines both show attenuated airway responsiveness to methacholine as measured by lung resistance. Thus, while compromise of the Ptges/ PGE2/Ptger2 pathway does not alter airway responsiveness, genetic modulation that elevates PGE2 levels in the lung attenuates airway responsiveness.




This article has been cited by other articles:


Home page
Eur Respir JHome page
B. Kapitein, M. O. Hoekstra, E. H. J. Nijhuis, D. J. Hijnen, H. G. M. Arets, J. L. L. Kimpen, and E. F. Knol
Gene expression in CD4+ T-cells reflects heterogeneity in infant wheezing phenotypes
Eur. Respir. J., November 1, 2008; 32(5): 1203 - 1212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. A. Mall, J. R. Harkema, J. B. Trojanek, D. Treis, A. Livraghi, S. Schubert, Z. Zhou, S. M. Kreda, S. L. Tilley, E. J. Hudson, et al.
Development of Chronic Bronchitis and Emphysema in {beta}-Epithelial Na+ Channel-Overexpressing Mice
Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 730 - 742.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. L. Larsen, J. Loader, C. Fratelli, J.-k. B. Kang, A. Dakhama, and G. N. Colasurdo
Modulation of airway responses by prostaglandins in young and fully grown rabbits
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L239 - L244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. D. N'Guessan, M. O. Etouem, B. Schmeck, A. C. Hocke, S. Scharf, K. Vardarova, B. Opitz, A. Flieger, N. Suttorp, and S. Hippenstiel
Legionella pneumophila-induced PKC{alpha}-, MAPK-, and NF-{kappa}B-dependent COX-2 expression in human lung epithelium
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L267 - L277.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. K. Lovgren, L. A. Jania, J. M. Hartney, K. K. Parsons, L. P. Audoly, G. A. FitzGerald, S. L. Tilley, and B. H. Koller
COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, August 1, 2006; 291(2): L144 - L156.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. D. N'Guessan, S. Hippenstiel, M. O. Etouem, J. Zahlten, W. Beermann, D. Lindner, B. Opitz, M. Witzenrath, S. Rosseau, N. Suttorp, et al.
Streptococcus pneumoniae induced p38 MAPK- and NF-{kappa}B-dependent COX-2 expression in human lung epithelium
Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1131 - L1138.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.